Dr. Elena Shagisultanova
Claim this profileUniversity of Colorado Cancer Center
Studies Breast Cancer
Studies Breast cancer
4 reported clinical trials
10 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
Stage IV
2Breast Cancer
Stage III
Stage IV
HER2 positive
Affiliated Hospitals
Clinical Trials Elena Shagisultanova is currently running
Triple Drug Combo
for Advanced Breast Cancer
The purpose of this study is to evaluate the safety and efficacy of the three-drug combination of tucatinib, trastuzumab, and eribulin in patients with de novo and recurrent unresectable metastatic HER-2/neu positive breast cancer as assessed by ORR, PFS and OS after prior treatment with a taxane, trastuzumab, and T-DM1.
Recruiting3 awards Phase 217 criteria
Alpelisib + Tucatinib
for Breast Cancer
This trial tests a combination of two drugs, tucatinib and alpelisib, in patients with a specific type of advanced breast cancer. These patients have a genetic mutation and a type of cancer that may not respond well to standard treatments. The drugs work by blocking signals that help cancer cells grow. Alpelisib is approved for treating certain types of advanced breast cancer.
Recruiting1 award Phase 1 & 211 criteria
More about Elena Shagisultanova
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Elena Shagisultanova has experience with
- Tucatinib
- Alpelisib
- Abemaciclib
- Anastrozole
- Exemestane
- Imlunestrant
Breakdown of trials Elena Shagisultanova has run
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elena Shagisultanova specialize in?
Elena Shagisultanova focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Elena Shagisultanova currently recruiting for clinical trials?
Yes, Elena Shagisultanova is currently recruiting for 3 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Elena Shagisultanova has studied deeply?
Yes, Elena Shagisultanova has studied treatments such as Tucatinib, Alpelisib, Abemaciclib.
What is the best way to schedule an appointment with Elena Shagisultanova?
Apply for one of the trials that Elena Shagisultanova is conducting.
What is the office address of Elena Shagisultanova?
The office of Elena Shagisultanova is located at: University of Colorado Cancer Center, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.